Q1 2021 13F Holders as of 31 Mar 2021
-
Type / Class
-
Equity / Common Stock
-
Total 13F shares
-
33,255,601
-
Share change
-
+1,907,071
-
Total reported value
-
$969,057,123
-
Price per share
-
$29.27
-
Number of holders
-
69
-
Value change
-
+$55,820,261
-
Number of buys
-
24
-
Number of sells
-
28
Institutional Holders of Kronos Bio, Inc. - Common Stock (KRON) as of Q1 2021
As of 31 Mar 2021,
Kronos Bio, Inc. - Common Stock (KRON) was held by
69 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
33,255,601 shares.
The largest 10 holders included
Omega Fund Management, LLC, Capital Research Global Investors, PERCEPTIVE ADVISORS LLC, PRICE T ROWE ASSOCIATES INC /MD/, Capital World Investors, FMR LLC, BlackRock Inc., JPMORGAN CHASE & CO, VANGUARD GROUP INC, and Wildcat Capital Management, LLC.
This page lists
69
institutional shareholders reporting positions in this security
for the Q1 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.